The relative potency in the hypothalamic-pituitary-adrenal (HPA) suppression of both prednisolone and betamethasone was examined in an acute study with normal volunteers and in a chronic study with glucocorticoid-treated patients. Circadian rhythm of plasma cortisol was studied after a single dose administration of 5 to 30 mg prednisolone or 0.5 to 3.0 mg betamethasone at 08 : 00 hr. Morning-rise of plasma cortisol occurred on the morning after the administration of 30 mg or less prednisolone but no morning rise was noted after the administration of 1.0 mg or more betamethasone. Plasma ACTH was slightly elevated on the morning after 30 mg prednisolone administration but showed low levels throughout the night after 3.0 mg betamethasone administration.
Both prednisolone and betamethasone are the glucocorticoids used most frequently in Japan at present. They are often simply exchanged for each other in the dose ratio of 10:1, because a single tablet contains either 5 mg of prendnisolone or 0.5 mg of betamethasone as an equivalent dose. This equivalency, however, has been decided on the basis of very early reports (Silber, 1959; Tolksdorf, 1959; Boland, 1961; Roberts, 1962) .
Later, Thorn and his colleagues (Harter, 1966; Thorn and Lauler, 1972) classified glucocorticoid derivatives into short-acting, intermediate-acting and long-acting on the basis of their duration of suppressive effect on human hypothalamic-pituitary-adrenal (HPA) function. In their studies, prednisolon e has been classified as short-acting and betamethasone as long-acting. Nevertheless, few studies have been made on the difference between their suppressive effects. on HPA function in the practical field. Examination for acute effect Six healthy male volunteers (# 1-6) aged 28 to 42 years were studied. All subjects were members of the medical or paramedical staff of Osaka University Hospital. They were all physically normal, having no history of endocrine, renal, hepatic or cardiovascular disease and without any self-medications. All experiments were performed within their daily activity patterns with usual sleep. All blood samples were drawn by venipuncture even during the sleep period.
In Subject #1, hrs blood samples were drawn every 2-4hr through 28 hrs from 08:00hr. Similar blood samplings were repeated 3 times at intervals of one week. No drug was given in the first experiment. In the 2nd experiment 10 mg of prednisolone and in the 3rd experiment 1.0 mg of betamethasone were administered at 08: 00 hr immediately after the first blood sampling. Both prednisolone (Predonine) and betamethasone (Rinderon) were purchased from Shianogi Pharmaceutical Co. Ltd., Osaka, Japan.
In 3 volunteers (Subjects 1-3), blood was sampled successively throughout 48 hrs at 12 hr-intervals. The blood samplings were repeated nine times in each subject in the same manner at intervals of about 2 weeks. In the first study no drug was given. Then in the remaining 8 studies, 5, 10, 20 or 30 mg of prednisolone or 0.5, 1.0, 2.0 or 3.0 mg of betamethasone was administered in random order in a single dose at 08: 00 hr immediately after the first blood was sampled.
In 3 other volunteers (Subjects 4-6), blood was sampled every 2-4 hr throughout night after the administration of 30 mg prednisolone at 08: 00 hr or after the administration of 3.0 mg betamethasone at 08: 00 hr 2 weeks later. (Murphy, 1969; Ballard et al., 1975) and that the half-life of prednisolone is known to be about 200 min (Peterson, 1959) . tisol in 3 experiments with Subject #1 are shown in Fig. 1 . In the first experiment when no drug was given, the circadian rhythm showed a normal pattern with the peak at 08:00 hr and the nadir at 02:00 hr. When a single dose of 10 mg prednisolone was administered at 08 : 00 hr in the second experiment, plasma cortisol showed low levels throughout the night but rose to a near control level at 08:00 hr on the next morning. However, when a single dose of 1.0mg betamethasone was given in the third experiment, plasma cortisol showed consistent low levels throughout 28 hrs and no morning rise occurred with this treatment. The individual variations in plasma cortisol in 3 normal subjects (#1-3) after a single administration of various doses of either prednisolone or betamethasone are shown in Fig. 2 . Even when such a large dose as 30mg of prednisolone was administered, the values at 08:00hr on the following day were elevated to nearly normal levels. On the other hand, when a single dose of 1.0 mg or more of betamethasone was administered, no morning rise was noted at 08:00 hr on the second day.
The circadian variations in plasma cortisol and ACTH in 3 normal subjects (4-6) after a single dose administration of either 30 mg prednisolone or 3.0 mg betamethasone at 08:00 hr are shown in Fig. 3 . Plasma cortisol levels in each subject showed an obvious morning rise after the administration of 30 mg prednisolone. Plasma ACTH levels also tended to rise after 04:00 hr. On the other hand, after the administration of 3.0 mg betamethasone at 08:00 hr, plasma cortisol levels were extremely low throughout the night and showed no morning rise and plasma ACTH levels tended to decline toward the following morning.
2. Chronic effect on the adrenocortical responsiveness to ACTH in patients receiving glucocorticoid therapy Plasma cortisol levels in patients before glucocorticoid therapy were significantly lower than in normal subjects both before (p<0.01) and 60 min after (p<0.05) ACTH injection (Table 1) . Therefore, all plasma cortisol values in patients receiving glucocorticoids were compared to the values in the untreated patients instead of the values in normal subjects.
The mean basal cortisol levels in patients receiving 10 mg or more of prednisolone daily were significantly lower than those in the untreated patients, but the value in patients receiving 5 mg once every morning did not differ significantly (p> 0.1). The cortisol level measured 60 min after ACTH was suppressed to less than 5.0 pg/dl in patients who received 15 mg or more of prednisolone daily. The patients receiving 10mg prednisolone in daily divided doses also showed a low basal cortisol level and poor responsiveness to ACTH, but those who received 10mg in a single dose every morning showed a higher basal level and (Fig. 4) . Table 2 shows the plasma cortisol responsiveness to ACTH in patients treated. with the alternate-day regimen. Compared. to the results in the daily regimen with prednisolone (Table 1) , both the basal level and response to ACTH showed striking improvement even when such large doses as 60 or 50mg were administered every other day. Most of the basal cortisol levels and the increment after ACTH injection obtained from the patients receiving 30mg or less of prednisolone every other day did not signi ficantly (p> 0.05) differ from the values in the untreated patients (Table 2) . However, both cortisol levels and the response to ACTH in 5 patients receiving 1.0mg betamethasone every other day were markedly suppressed and they were comparable to the results in patients receiving daily 0.5 mg betamethasone, as shown in Table 1 . 
Discussion
The fact that so-called short-acting steroids and long-acting steroids have almost comparable half-lives in plasma (Melby, 1974; Ballard et al., 1975) suggests that the duration of biological actions of glucocorticoids is not determined by its presence in the circulation but may be determined by such factors as its low affinity for transcortin, relative slow disappearance from plasma and/or the duration of action within target cells (Ballard et al., 1975; Axelrod , 1976 ; Meikle and Tyler, 1977) .
In particular, tne difference in the duration of the HPA suppression seems to be accounted for by the difference in the mode of action within the binding site of the hypothalamus or the pituitary gland.
There have been many reports on the effect of dexamethasone on the HPA suppression (Hender, 1967; Easton et al., 1971; Ballard et al., 1975; Meikle and Tyler, 1977) , but very few reports (Harter, 1966) are available on the effect of betamethasone, another long-acting steroid which is one of the most popular glucocorticoids in Japan at present. Thus, it seems necessary to assess its effect on the HPA suppression exactly.
As it has been well established that the circadian cortisol rhythm is least affected when a single dose of glucocorticoids is administered in the morning (Nichols et al., 1965; Grant et al., 1965) , the acute effect on the HPA function was studied by means of a single administration at 08:00 hr in the present study. The present findings based on the changes in the circadian rhythm of plasma cortisol or ACTH indicate that the acute suppressive effect of a single administration of prednisolone on the HPA system is mild and continues no longer than 24hrs, even when doses as large as 30mg are administered.
On the contrary, the effect of betamethasone given in the same manner seems to be much stronger and to continue longer than 24 hrs, even when such a small dose as 1.0 mg is given. The chronic effect of the two steroids was examined with the rapid ACTH test in this study. Even though this test was developed as a screening test for assessing the adrenocortical function by Wood et al. (1965) , the results have been evaluated to reflect well the general status of the HPA function in glucocorticoid-treated patients (Kehlet and Binder, 1973) . It is therefore felt that the present data represent the general status of the HPA function in patients receiving either prednisolone or betamethasone.
The present results indicate that the long-term administration of 10mg or more of prednisolone in daily divided doses suppresses the HPA function but a single administration of 10mg in the morning can reduce the HPA suppression. This result is consistent with the report of Myles et al. (1971) who found depressed 10:00hr plasma, cortisol levels in patients treated with prednisolone twice daily but found nearly normal cortisol levels in the same patients with a single daily administration.
In the present study, the adrenocortical responsiveness was evaluated only on the basis of presently administered steroid doses without considering the duration of the therapy or the total amount of steroids. Therefore, even those who received only 5 mg of prednisolone showed improved but still subnormal responses, because they had been treated with larger doses for a long time.
On the contrary, a long-term administration of betamethasone, even in a single dose of 0.5mg in the morning, was found to suppress the HPA function completely.
The alternate-day glucocorticoid therapy with a single dose in the morning of every second day was first proposed by Harter et al. (1963) , and many authors have found that such a regimen diminishes side effects of glucocorticoids and produces little or no suppression on the HPA function (Soyka, and Saxena, 1965; Fleisher and Pellecchia, 1965; Ackerman and Nolan, 1968 ; MacGregor et al., 1969; Easton et al., 1971 ). The present study based on the plasma cortisol responsiveness to ACTH also clearly indicates that the HPA function can be et al.
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Japon, October 1980 kept nearly normal during the alternate-day therapy with such a large dose as 60 mg prednisolone.
The reason why the HPA function does not differ so much between larger doses group and smaller doses group may be due to the difference in duration of the therapy, because the dose of prednisolone has gradually been tapered and rapid ACTH tests have been undertaken repeatedly in the same patients at different doses.
In contrast with the prednisolone therapy, the adrenocortical responsiveness was cornpletey suppressed by the alternate-day therapy with betamethasone in even such a small dose as 1.0 mg. This result is consistent with earlier reports which showed that the HPA function is impaired if the alternate-day therapy is performed with long-acting steroids (Harter, 1966 ; Rabhan, 1968; Easton et al., 1971) . The results of the present study indicate that the suppressibility of the HPA axis with so-called equivalent dosages of glucocorticoids with comparable anti-inflammatory activity is different and that the suppressive effect of long-term glucocorticoid therapy on the HPA function may be almost parallel to the acute suppressive effect on the circadian rhythm of plasma ACTH or cortisol.
